- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2196-3061
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treating Negative Symptoms in Schizophrenia: an Update ; day:8 ; month:4 ; year:2016 ; pages:1-18
Current treatment options in psychiatry ; (8.4.2016), 1-18
- Urheber
-
Remington, Gary
- Beteiligte Personen und Organisationen
-
Foussias, George
Fervaha, Gagan
Agid, Ofer
Takeuchi, Hiroyoshi
Lee, Jimmy
Hahn, Margaret
SpringerLink (Online service)
- DOI
-
10.1007/s40501-016-0075-8
- URN
-
urn:nbn:de:1111-2016040916436
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Remington, Gary
- Foussias, George
- Fervaha, Gagan
- Agid, Ofer
- Takeuchi, Hiroyoshi
- Lee, Jimmy
- Hahn, Margaret
- SpringerLink (Online service)
Ähnliche Objekte (12)
Schizophrenia: positive and negative symptoms and syndromes
NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE PREVAILING CHALLENGES
Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports
Irregularity of visual motion perception and negative symptoms in schizophrenia
Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
Treatment of negative symptoms in schizophrenia: a challenge for clinical research
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms
The network characteristics in schizophrenia with prominent negative symptoms: a multimodal fusion study
Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update
Schizophrenia: positive and negative symptoms and syndromes
NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE PREVAILING CHALLENGES
Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports
Irregularity of visual motion perception and negative symptoms in schizophrenia
Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
Treatment of negative symptoms in schizophrenia: a challenge for clinical research
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms
The network characteristics in schizophrenia with prominent negative symptoms: a multimodal fusion study
Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update
Schizophrenia: positive and negative symptoms and syndromes
NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE PREVAILING CHALLENGES
Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports
Irregularity of visual motion perception and negative symptoms in schizophrenia
Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
Treatment of negative symptoms in schizophrenia: a challenge for clinical research
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms
The network characteristics in schizophrenia with prominent negative symptoms: a multimodal fusion study
Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece